Enterprise Value
100.5M
Cash
144.9M
Avg Qtr Burn
-10.56M
Short % of Float
6.58%
Insider Ownership
7.83%
Institutional Own.
51.74%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
ACU193 Details Alzheimer's disease | Phase 2 Initiation |